BuMel - National Cancer Institute

BuMel - National Cancer Institute

CANCER TREATMENT

• Types of Treatment
• Side Effects
• Clinical Trials Information for Patients and Caregivers
• A to Z List of Cancer Drugs
  • Drugs Approved for Different Types of Cancer
  • Drugs Approved for Conditions Related to Cancer
  • Off-Label Drug Use in Cancer Treatment
• Complementary & Alternative Medicine (CAM)
• Questions to Ask about Your Treatment
• Research

BuMel Combination for Neuroblastoma

We’ve added a new drug summary on BuMel. It’s a combination of the drugs busulfan and melphalan and is used in the treatment of neuroblastoma.

BuMel

• 
• 
• 
• 
• 
• 
• 

This page contains brief information about the drug combination called BuMel. The drugs in the combination are listed, and links to individual drug summaries are included.

Drugs in the BuMel combination:

Bu	= Busulfan
Mel	= Melphalan Hydrochloride

Chemotherapy is often given as a combination of drugs. Combinations usually work better than single drugs because different drugs kill cancer cells in different ways.

Each of the drugs in this combination is approved by the Food and Drug Administration (FDA) to treat cancer or conditions related to cancer.

Use in Cancer

BuMel is used to treat:

• Neuroblastoma that is high risk. It is used to prepare patients for a stem cell transplant.

This combination may also be used with other drugs or treatments or to treat other types of cancer.

More About BuMel

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Important: The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.

• Posted: June 23, 2016
• Updated: June 23, 2016